You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HRD

Showing 26 - 50 of 182
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Homologous Recombination Deficiency in Chinese Ovarian Cancer

Not yet recruiting
  • Ovarian Cancer
  • +2 more
  • PARP inhibitor
  • Nanjing, Jiangsu, China
    Xiaoxiang Chen, MD,PhD
Sep 4, 2021

Homologous Recombination Deficient Solid Tumors Trial in Germantown (Combination drug)

Not yet recruiting
  • Homologous Recombination Deficient Solid Tumors
  • Combination drug
  • Germantown, Tennessee
    West Cancer Center
Aug 3, 2021

Premenopausal HR+/HER2- Metastatic Breast Cancer Trial in Seoul (Pabociclib, Endocrine, Talazoparib, Atezolizumab, Pabociclib,

Not yet recruiting
  • Premenopausal HR+/HER2- Metastatic Breast Cancer
  • Pabociclib, Endocrine, Talazoparib, Atezolizumab
  • Pabociclib, Endocrine, Talazoparib,
  • Seoul, Korea, Republic of
    Samsung mendical Center
Jul 26, 2021

Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer Trial in Italy (Carboplatin, Paclitaxel,

Recruiting
  • Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer
  • Legnago, Italy
  • +6 more
Aug 24, 2021

Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity Trial in Canada, United States (OLAPARIB)

Completed
Has Results
  • Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
  • Anchorage, Alaska
  • +46 more
Mar 22, 2022

Breast Cancer Trial in Amsterdam (Intensified Cyclophophamide, Carboplatin and Thiotepa, dose dense adriamycine and

Terminated
  • Breast Cancer
  • Intensified Cyclophophamide, Carboplatin and Thiotepa
  • dose dense adriamycine and cyclophosphamide
  • Amsterdam, Netherlands
    NKI-AVL
Jan 20, 2021

A Training Set for the HRD Model in EOC

Recruiting
  • Epithelial Ovarian Cancer
  • +5 more
  • Homologous recombination deficiency model
  • Beijing, Beijing, China
    Lei Li
Dec 2, 2020

Triple Negative Breast Cancer Trial in United States (Cisplatin, Paclitaxel)

Active, not recruiting
Has Results
  • Triple Negative Breast Cancer
  • Birmingham, Alabama
  • +19 more
Feb 14, 2022

Collect Real-world Clinical and Patient-reported Outcomes in

Recruiting
  • Ovarian Cancer
    • Aachen, Germany
    • +64 more
    Jul 29, 2022

    Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

    Not yet recruiting
    • Ovarian Cancer
    • Olaparib tablet
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Nov 1, 2023

    Homologous Recombination Inquiry Through Ovarian Malignancy

    Completed
    • Ovarian Cancer
    • +2 more
      • Niigata city, Niigata Prefecture, Japan
        Niigata University Graduate School of Medical and Dental Science
      Jan 19, 2023

      HER2-negative Breast Cancer Trial in Chengdu (AT regimen, TP regimen)

      Unknown status
      • HER2-negative Breast Cancer
      • AT regimen
      • TP regimen
      • Chengdu, Sichuan, China
        Department of breast surgery, Sichuan Provincial People's Hospit
      Jul 30, 2020

      Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

      Recruiting
      • Lung Cancer
        • Shanghai, China
          Shanghai Chest Hospital
        Jul 20, 2023

        Homologous Recombination Deficiency Among Newly Diagnosed,

        Recruiting
        • Fallopian Tube Cancer
          • Arkhangelsk, Russian Federation
          • +24 more
          Jul 18, 2022

          High-Grade Ovarian Cancer Terms of Homologous Recombination

          Not yet recruiting
          • Ovarian Cancer
          • +2 more
          • Standard of care
          • (no location specified)
          Oct 7, 2022

          HER2-negative Metastatic Breast Cancer Trial in Nashville (DAN-222, Niraparib)

          Recruiting
          • HER2-negative Metastatic Breast Cancer
          • Nashville, Tennessee
            Sarah Cannon Research Institute/Tennessee Oncology
          Feb 25, 2022

          Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

          Not yet recruiting
          • Breast Cancer
          • Marseille, France
            Institut Paoli Calmettes
          Aug 9, 2023

          Cancer Trial in Melbourne (Pamiparib, Tislelizumab)

          Recruiting
          • Cancer
          • Melbourne, Victoria, Australia
            Peter MacCallum Cancer Centre
          Mar 3, 2022

          Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia

          Not yet recruiting
          • Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia
          • identify biomarkers
          • (no location specified)
          May 13, 2023

          Breast Cancer, Breast Cancer Metastatic Trial in Spain (Niraparib 100 MG, Aromatase Inhibitors)

          Terminated
          • Breast Cancer
          • Breast Cancer Metastatic
          • Niraparib 100 MG
          • Aromatase Inhibitors
          • A Coruña, Spain
          • +9 more
          Jan 17, 2023

          Advanced Solid Tumors Trial in Worldwide (Olaparib)

          Recruiting
          • Advanced Solid Neoplasms
          • Tucson, Arizona
          • +128 more
          Aug 18, 2022

          Breast Cancer, Triple Negative Breast Tumors, HRpos Breast Tumors Trial in Germany (drug, procedure, other)

          Completed
          • Breast Cancer
          • +3 more
          • Esslingen am Neckar, Baden-Württemberg, Germany
          • +11 more
          Mar 13, 2020

          Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)

          Not yet recruiting
          • Pancreatic Adenocarcinoma
          • Homologous Recombination Deficiency
          • (no location specified)
          Oct 18, 2023

          Advanced Solid Tumors, HRD, BRCA Mutation Trial in Tianjin (HWH340 tablet)

          Unknown status
          • Advanced Solid Tumors
          • +2 more
          • HWH340 tablet
          • Tianjin, Tianjin, China
            Tianjin medical university cancer insititute & hospital
          Feb 12, 2020

          Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt

          Not yet recruiting
          • Advanced Ovarian Cancer
          • None (Observational Study)
          • (no location specified)
          Mar 8, 2023